Funder
National Center for Advancing Translational Sciences
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Balk SP. Androgen receptor as a target in androgen- independent prostate cancer. Urology. 2002;60(3):132–8. https://doi.org/10.1016/S0090-4295(02)01593-5.
2. NCI Dictionary of Cancer Terms [database on the Internet]2019. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/androgen-ablation. Accessed:
3. Nuhn P, De Bono JS, Fizazi K, Freedland SJ, Grilli M, Kantoff PW, et al. Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology. Eur Urol. 2019;75(1):88–99. https://doi.org/10.1016/j.eururo.2018.03.028.
4. Crawford ED, Higano CS, Shore ND, Hussain M, Petrylak DP. Treating patients with metastatic castration resistant prostate cancer: a comprehensive review of available therapies. J Urol. 2015;194(6):1537–47. https://doi.org/10.1016/j.juro.2015.06.106.
5. Supplements OoD. Selenium. National Institutes of Health 2018. https://ods.od.nih.gov/factsheets/Selenium-HealthProfessional/.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献